Thursday, February 3, 2011

Stock Earnings Allergan's earnings climb 19% February 3-2011 $70.72

Sales of Botox help lift the Irvine company's fourth-quarter profit, but net income's increase was less than what some analysts had expected. Demand for the firm's Lap-Band product slid 10%.
Sales of Botox help lift the Irvine company's fourth-quarter profit, but net income's increase was less than what some analysts had expected. Demand for the firm's Lap-Band product slid 10%.
$70.72 -0.07 (0.10%) 52Wk Range: 55.08 - 74.89

No comments:

Post a Comment